-SEC Filing
Oncolytics Biotech Receives FDA Fast Track Designation For The Treatment Of Advanced/Metastatic Pancreatic Cancer
Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1